| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory of Experimental Medicine, Université libre de Bruxelles, B-1070 Brussels, Belgium
Address all correspondence and requests for reprints to: M. I. Darville, Laboratory of Experimental Medicine, Université libre de Bruxelles, Route de Lennik, 808 CP618, B-1070 Brussels, Belgium. E-mail: mdarvill{at}ulb.ac.be.
Nitric oxide, generated by the inducible form of nitric oxide synthase (iNOS), is a potential mediator of cytokine-induced ß-cell dysfunction in type 1 diabetes mellitus. We have previously shown that cytokine-induced iNOS expression is cycloheximide (CHX) sensitive and requires nuclear factor-
B (NF-
B) activation. In the present study, we show that an octamer motif located 20 bp downstream of the proximal NF-
B binding site in the rat iNOS promoter is critical for IL-1ß and interferon-
induction of promoter activity in rat primary ß-cells and insulin-producing RINm5F cells. In gel shift assays, the octamer motif bound constitutively the transcription factor Oct1. Neither Oct1 nor NF-
B binding activities were blocked by CHX, suggesting that other factor(s) synthesized in response to IL-1ß contribute to iNOS promoter induction. The high mobility group (HMG)-I(Y) protein also bound the proximal iNOS promoter region. HMG-I(Y) binding was decreased in cells treated with CHX and HMG-I(Y) silencing by RNA interference reduced IL-1ß-induced iNOS promoter activity. These results suggest that Oct1, NF-
B, and HMG-I(Y) cooperate for transactivation of the iNOS promoter in pancreatic ß-cells.
This article has been cited by other articles:
![]() |
F. Ortis, A. K. Cardozo, D. Crispim, J. Storling, T. Mandrup-Poulsen, and D. L. Eizirik Cytokine-Induced Proapoptotic Gene Expression in Insulin-Producing Cells Is Related to Rapid, Sustained, and Nonoscillatory Nuclear Factor-{kappa}B Activation Mol. Endocrinol., August 1, 2006; 20(8): 1867 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. KUTLU, N. NAAMANE, L. BERTHOU, and D. L. EIZIRIK New Approaches for in Silico Identification of Cytokine-Modified {beta} Cell Gene Networks Ann. N.Y. Acad. Sci., December 1, 2004; 1037(1): 41 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kharroubi, L. Ladriere, A. K. Cardozo, Z. Dogusan, M. Cnop, and D. L. Eizirik Free Fatty Acids and Cytokines Induce Pancreatic {beta}-Cell Apoptosis by Different Mechanisms: Role of Nuclear Factor-{kappa}B and Endoplasmic Reticulum Stress Endocrinology, November 1, 2004; 145(11): 5087 - 5096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |